Dai-ichi Life Holdings’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-191,692
Closed -$15.2M 190
2016
Q3
$15.2M Sell
191,692
-741
-0.4% -$60.2K 0.46% 40
2016
Q2
$16.1M Sell
192,433
-38,278
-17% -$3.4M 0.48% 43
2016
Q1
$21.2M Buy
230,711
+3,685
+2% +$332K 0.64% 26
2015
Q4
$23M Sell
227,026
-7,268
-3% -$756K 0.72% 23
2015
Q3
$23M Buy
234,294
+23,507
+11% +$2.61M 0.71% 23
2015
Q2
$24.7M Sell
210,787
-31,900
-13% -$3.49M 0.74% 19
2015
Q1
$23.8M Sell
242,687
-28,530
-11% -$2.9M 0.67% 20
2014
Q4
$25.6M Sell
271,217
-942
-0.3% -$97.4K 0.74% 20
2014
Q3
$29M Buy
272,159
+25,966
+11% +$2.54M 0.86% 15
2014
Q2
$20.4M Sell
246,193
-46,863
-16% -$3.65M 0.64% 27
2014
Q1
$20.8M Sell
293,056
-26,141
-8% -$2.05M 0.66% 25
2013
Q4
$24M Buy
319,197
+13,509
+4% +$941K 0.74% 22
2013
Q3
$19.2M Sell
305,688
-40,701
-12% -$2.43M 0.67% 27
2013
Q2
$17.7M Buy
+346,389
New +$18.1M 0.62% 30

Other funds holding GILD

Dai-ichi Life Holdings's GILD Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 191,692 shares — an estimated $15.2M sold.

Dai-ichi Life Holdings first reported a position in GILD in Q2 2013 and held it in 14 quarters. The position peaked at $29M in Q3 2014. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 191,692 Gilead Sciences shares in Q4 2016, an estimated $15.2M.
  • Dai-ichi Life Holdings first reported a position in Gilead Sciences in Q2 2013 and held it in 14 quarters.
  • Dai-ichi Life Holdings's Gilead Sciences position peaked at $29M in Q3 2014.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.